Last reviewed · How we verify

LOPRAZOLAM

FDA-approved active Small molecule Quality 17/100

At a glance

Generic nameLOPRAZOLAM
Drug classloprazolam
TargetGABA-A receptor alpha-1/beta-3/gamma-2
ModalitySmall molecule
Therapeutic areaNeuroscience
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: